. These interesting and biochemically active compounds possess biological activity covering a wide range of antibacterial (Mundt et al.
INTRODUCTION
Cyanobacteria represent a group of Gram-negative photoautotrophic prokaryotes thriving in almost all aquatic and terrestrial habitats on earth, including extreme environments. This widespread distribution reflects the tolerance of Cyanobacteria towards environmental stress due, inter alia, to a broad spectrum of specific properties in physiology (Uzair et al., 2012) . Generally, microorganisms forming microbial mats in extreme environments have been recently identified as a good source of bioactive compounds for different biotechnological applications (Harvey, 2000; Dobretsov et al., 2011) .
Modern research has focused on a variety of bioactive compounds produced by Cyanobacteria. After analysis of a great number of marine cyanobacterial natural products, lipopeptides seem to prevail followed at much lesser proportions by amino acids, fatty acids, macrolides and amides (Burja et al., 2001; Cave Cyanobacteria -thriving in an 'extreme' environment with interesting species biodiversity -are supposed to be a potential source of bioactive compounds. Lipid extracts from pure cultures of two recently established Cyanobacteria from Greek caves, Toxopsis calypsus and Phormidium melanochroun, were used for antibacterial screening against human pathogenic bacteria (reference and clinical isolates). Antimicrobial Susceptibility testing for both taxa was carried out using the disc-diffusion (Kirby Bauer) method, while preliminary data applying the standard broth microdilution method for the determination of the Minimal Inhibitory Concentration (MIC) are given only for T. calypsus. Antibacterial activity was demonstrated against the Gram-positive clinical and reference bacteria, mostly pronounced in enterococci; no activity was observed against the Gram-negative bacteria. The above screening is the first record of antibacterial activity from lipid extracts of cave Cyanobacteria enhancing the importance of cave microbiota and the necessity for cave conservation. one volume of pre-equilibrated 87% ethanol (Galanos & Kapoulas, 1962) . The PLs were further fractioned by Thin Layer Chromatography (TLC) on ten (10) TLC plates using chloroform/acetone/methanol/ acetic acid/water at a ratio of 100:40:34:10:10 (v/v/v/v/v) as developing system. Appropriate standards of phospho-and glycol-lipids were also used. After exposure of the TLC plate to I 2 vapor, the fractions of PLs were scraped off separately, centrifuged, and the organic solvents were phased by adding appropriate volumes of chloroform, methanol and water at a ratio of 1:2:0.8 (v/v/v). All reagents and chemicals were of analytical grade and supplied by Merck (Darmstadt, Germany). The chromatographic material used for TLC was silica gel H-60 (Merck, Darmstadt, Germany).
Antibacterial activity determination
The potential antibacterial activity was tested in both Cyanobacteria strains by the disk diffusion method with Mueller-Hinton II agar (OXOID, UK) according to CLSI guidelines. Dried extracts were dissolved in methanol. The plates were inoculated with a suspension of each strain adjusted to a turbidity of 0.5 McFarland. Sterilized blank (3 mm Chr Whatman) paper disks (6 mm diameter) were applied to the surface of the inoculated agar and were loaded with a total amount of 10 μl and 20 μl of each extract solution. The antibiotic disks (BIORAD, UK) gentamicin 10 μg (GEN), ampicillin 10 μg (AMP), cefoxitin 30 μg (FOX), tetracycline 30 μg (TET), ciprofloxacin 5 μg (CIP) and co-trimoxazole 1.25 / 23.75 μg (SXT) were used as positive controls depending of the bacterial species. Methanol alone was used as a negative control since a volume of V ≥5 μl pure methanol was inhibitory to bacterial growth. The plates were left to dry for 15 min and were incubated for 18 h at 35º ± 2ºC. For all agents the diameters of zones of inhibition were measured to the nearest millimeter and for the positive controls the results were interpreted according to CLSI (2012) breakpoints. Each fraction of PLs, as well as the NLs as a whole, was tested in vitro for their ability to inhibit growth of the following eight reference or clinical isolates: After the initial evaluation of antibacterial activity, the Minimum Inhibitory Concentrations (MICs) were determined only for T. calypsus by broth microdilution method as recommended by CLSI. The tests were performed in sterile 96-well microtiter plates. Briefly, 50 μl of two-fold serial dilutions of examined samples was added to 50 μl microbial suspensions adjusted to yield approximately 5×10 5 CFU/ml. MIC was encountered as the lowest concentration of the examined sample that inhibits the visible microbial growth after 24 h incubation at 37ºC. Negative controls (methanol) were included, too. and nutrient limitation), antibiotic effectiveness by cave bacteria has recently been recorded (Montano & Henderson, 2013) ; however, no studies have yet identified the antibacterial potential of cyanobacterial isolates from caves.
Exploitation of new natural products as antibacterial agents against resistant pathogens is very important for clinical medicine and public health, and a limited number of new antimicrobial classes have been developed by the international pharmaceutical industry in the last 20 years (Infectious Diseases Society of America, 2007) . The aim of the present study is to assess the potential antibacterial activity of extracts from two recently established Cyanobacteria from Greek caves, i.e. Toxopsis calypsus and Phormidium melanochroun (Lamprinou et al., 2012 (Lamprinou et al., , 2013 . It is noted that cave environments are still relatively underexploited, and may prove to be a rich source of novel biodiversity possessing bioactive compounds potentially useful in biotechnology.
MATERIAL AND METHODS

Sampling
Fresh material, as scrapped mats and pieces of rocks of ≤5 g, was collected from 'Francthi' Cave (37°25'21.01"N, 22°17'51.18"N; altitude 12.5 m a.s.l.), an exposed, non typical cave, with partly collapsed roof, located in Argolida (Peloponnese, Greece). Sampling was conducted seasonally at seven selected sites from the entrance inwards. Temperature (average 18.26ºC, min 11.53ºC, max 25.94ºC), Relative Humidity (average 66.20%, min 50.73%, max 93.51%) and photosynthetically active radiation (average 3.09 μmol·s -1 ·m -2 , min 0.08 μmol·s -1 ·m -2 , max 26.70 μmol·s -1 ·m -2 ) were measured at each sampling site and sampling date by a LI-1400 data logger (LI-COR Biosciences, USA). Four subsamples were collected from each sampling site. Two of them were incubated in situ into sterile transparent vials and, the other two were partly fixed with formaldehyde solution at 2.5%. Enrichment cultures were obtained in flasks and petri dishes with culture media (BG11 o and BG11, Stanier et al., 1971 ) and under proper conditions (Gallenkamp, Sanyo incubator; 23ºC, 80% RH, 7 μmols·s -1 ·m -2 ). The two Cyanobacteria selected for antibacterial screening (Tables 1 a,b) were: (i) Toxopsis calypsus (type strain: ATHU-CY 3314, GenBank acc. Nr. JN695681-JN695685) found at the nearest to the entrance site, and (ii) Phormidium melanochroun (type strain: ATHU-CY 3315, GenBank acc. Nr. JQ692233) found in almost all sampling sites. The required time for attaining sufficient biomass for lipid extraction was 150-200 days.
Lipids Extraction and Thin Layer Chromatography (TLC)
Total lipids were extracted from cell suspensions of cultures using the Bligh Dyer method (Bligh & Dyer, 1959) . Total lipids (TLs) were then separated into polar (PLs) and neutral lipids (NLs) by countercurrent distributions in a binary system formed by mixing three volumes of pre-equilibrated petroleum ether and (i) against Enterococcus faecium (VRE) by the fractions T2 and T7 of T. calypsus, and by the fraction P3 of P. melanochroun, at a total volume of 20 μl, and (ii) against Enterococcus faecalis (ATCC) by the fraction T9 of T. calyspsus also at a total volume of 20 μl. One fraction of polar lipids (P7) from P. melanochroun showed no zone of inhibition eliminating the expected halo of pure methanol (see Table 1 a,b). The results obtained by the broth microdilution method (MICs) for T. calypsus confirm those of the disk diffusion method (Table 3) . Antibacterial activity of the 12 fractions of PLs (including NLs and PLs as a whole) extracted from T. calypsus was recorded against staphylococci and enterococci in MIC values 0.256 μg/ml and 0.512 μg/ml. Seven (7) fractions of PLs (T1-T3, T7-T10) showed the greatest MIC values against enterococci (0.256 μg/ml). Moreover, one of the above fractions (T10) showed antibacterial activity against S. aureus (MRSA) at MIC value of 0.256 μg/ml. The fractions T11 and T12 indicated no antibacterial activity at MIC ≥ 0.512 μg/ml.
RESULTS
Extraction of lipids from the Cyanobacteria T. calypsus and P. melanochroun yielded about 31 mg and 51 mg of total lipids (TLs), respectively. Polar lipids (PLs) were further fractioned by TLC, and after exposure in I 2 vapor a total of 12 and 10 bands were revealed for T. calypsus and P. melanochroun, respectively. The retention factors (Rfs) for each band of polar lipids compared to that of standards are shown in Table 2 .
As examined by the Kirby Bauer Method, each fraction of PLs from both Cyanobacteria species, as well as TLs, PLs and NLs as a whole, yielded an inhibition halo against the examined Gram-positive bacteria, whereas none of the examined lipids was effective against the Gram-negative bacteria (Tables 1 a,b) .
Among the Gram-positive bacteria, the reference and clinical isolates of enterococci were mostly affected since a greater number of fractions of PLs (including NLs and PLs as a whole) showed zones of inhibition. The highest zones of inhibition (20 mm) were observed: strains (ranging from 0.5 mg/ml to 512 mg/ml; e.g., Kaushik & Chauhan, 2008; Asthana et al., 2009; Kumar et al., 2012) . These data and future similar research on Phormidium melanochroun, accompanied by precise composition and characterization of these active compounds, are highly promising steps for developing effective antibiotics from cave Cyanobacteria in pharmaceutical industry. Extreme habitats experiencing steady or fluctuating exposure to one or more environmental factors, i.e. salinity, osmolality, desiccation, solar irradiance, barometric pressure, pH, temperature, nutrient limitation (Seufferheld et al., 2008; Dapkevicius, 2013) are considered as one of the most promising sources of biotechnologically useful compounds. As a result, several studies have been devoted to screening secondary metabolites produced by microorganisms inhabiting such environments (e.g., Harvey, 2000; Nicolaus et al., 2010; Chang et al., 2011; Singh & Gabani, 2011) . Caves are considered as extreme environments in terms of nutrient limitation and insufficient light with rather understudied microorganisms; thus, caves are promising sources for successful natural product research, justifying their conservation and our effort of screening the isolated Cyanobacteria.
DISCUSSION
Natural products have been attributed to a few genera within Cyanobacteria, given that some of them were proved to be polyphyletic groups, e.g. genus Lyngbya was shown to be composed of several phylogenetically distant and unrelated lineages (Sharp et al., 2009; Engene et al., 2010 Engene et al., , 2012 Engene et al., , 2013 Komárek et al., 2013) . Moreover, phylogenetic inferences of marine cyanobacterial strains responsible for over 100 bioactive secondary metabolites revealed an uneven taxonomic distribution, with a few groups being responsible for the vast majority of these molecules (Engene et al., 2013) . These data suggest a high degree of novel biodiversity among natural product-producing strains that was previously overlooked by traditional morphology-based taxonomic approaches.
The two species selected for this study are new Cyanobacteria from Greek caves established by both the traditional and the molecular (polyphasic) approach (Lamprinou et al., 2012 (Lamprinou et al., , 2013 : a) Phormidium melanochroun is an oscillatorialean species characterized by a blackish thick mucilaginous sheath (autapomorphic character), and b) Toxopsis calypsus is a nostocalean species characterized by both isopolar and heteropolar life cycle (autapomorphic character). The observed outcompeting behaviour of the former species towards other Cyanobacteria in our cultures and the fact that previous studies were focused on different antibacterial compounds extracted from genus Phormidium (e.g. Madhumathi et al., 2011; Vijaya Baskara Sethubathi & Prabu, 2012) making this genus a target in the search for a potential lipid antibacterial activity. On the other hand, the taxonomic position of the latter species (T. calypsus) among Nostocales has been crucial in the search for a similar activity of lipids, since the order Nostocales is known for intense antibacterial and antifungal activity and has been the focus of many relevant investigations with Nostoc and Anabaena being the most well studied genera (Mundt et al., 2001; Abdel-Raouf & Ibraheem, 2008; Asthana et al., 2009; Kausik et al., 2009) .
Lipids and some free fatty acids from microalgae and Cyanobacteria are known to display antibacterial properties (Borowitzka, 1995; Desbois & Smith, 2010; Plaza et al., 2010; Najdenski et al., 2013) . In our study, most of the lipids extracted from P. melanochroun and T. calypsus demonstrated potential activity against the Gram-positive clinical and reference bacteria with pronounced effectiveness against the enterococci; on the contrary, no activity was observed against the Gram-negative bacteria (cf. Ramadan et al., 2008) . Although the exact mechanism is rather unknown, lipids are supposed to be the responsible disrupting agents of the bacterial cellular membranes by penetrating into the thick peptidoglycan wall layer of the Gram-positive bacteria, but not affecting the thin peptidoglycan wall layer of the Gram-negative bacteria (Najdenski et al., 2013) .
The MIC values of lipids from Toxopsis calypsus (0.256 μg/ml) were highly active against all tested enterococci in comparison with previously reported MIC values from crude extracts of other cyanobacterial
